Company Filing History:
Years Active: 2020-2024
Title: Klaus Heinrich Schwamborn: Innovator in Vaccine Development
Introduction
Klaus Heinrich Schwamborn is a notable inventor based in Nantes, France. He has made significant contributions to the field of vaccine development, particularly in the area of respiratory tract infections. With a total of 9 patents to his name, Schwamborn's work has the potential to impact public health positively.
Latest Patents
Schwamborn's latest patents include a subunit vaccine for the treatment or prevention of respiratory tract infections. This invention relates to modified human metapneumovirus (hMPV) F proteins that are stabilized in the pre-fusion conformation, serving as vaccine candidates. The immunogenic compositions developed from these proteins aim to prevent and treat respiratory tract infections in human subjects.
Career Highlights
Throughout his career, Schwamborn has worked with various companies, including Pepmab B.V. and Forty Seven, Inc. His innovative approach to vaccine development has garnered attention in the scientific community and has led to advancements in immunology.
Collaborations
Some of his notable coworkers include Jaap Willem Back and Ronald Boshuizen. Their collaborative efforts have contributed to the success of Schwamborn's research and inventions.
Conclusion
Klaus Heinrich Schwamborn's work in vaccine development showcases his dedication to improving health outcomes through innovation. His contributions to the field are significant and continue to influence future research in respiratory infections.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.